Clinical Trial Update: A Dose-Escalation Study to Determine the Maximum Tolerated Dose of Arbaclofen Placarbil in Subjects With Alcohol Use Disorder [Phase 2]

View source ↗

Summary

A Phase 2 dose-escalation study to determine the maximum tolerated dose of arbaclofen placarbil in adults with alcohol use disorder; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder

Drugs mentioned

• Arbaclofen placarbil (arbaclofen placarbil)

Snippet

Sponsor: Indivior Inc. | Conditions: Alcohol Use Disorder | Phase 2 | Status: COMPLETED